Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network (AONC) operates a community-based oncology network that partners with independent oncology and hematology practices. Recurring company news covers practice additions, clinic openings, physician recruitment, and regional expansion across community cancer-care markets.
Company updates also address support services for partner practices, including in-house pharmacy, laboratory support, clinical trial access, back-office operations, and revenue-diversifying programs. News involving the network’s practices includes outpatient oncology services, infusion therapy, blood-disorder care, CAR T-cell therapy, bispecifics, radiopharmaceuticals, patient advocacy, and participation in community oncology policy and industry forums.
American Oncology Network (NYSE:AONC) will speak at the 2026 Community Oncology Alliance Annual Conference, April 28-29 in Orlando. AON leaders will deliver 11 sessions on topics including CAR T, radiopharmaceuticals, clinical trials, payer data, patient advocacy and careers in community oncology. AON will exhibit at booth 207.
Messino Cancer Centers (AONC) opened a new clinic in South Asheville on March 18, 2026, expanding to its sixth location at 1815 Hendersonville Road, Suite 103.
The clinic is open Tuesdays–Thursdays 8 AM–5 PM, includes an on-site lab, private exam rooms and an infusion suite with eight chairs; breast cancer care is available from Board-certified physicians Dr. Rachel Raab and Dr. Emily Miller.
Oncology Consultants (AONC) announced on March 5, 2026 that it has joined American Oncology Network (AON), expanding clinical trial access and operational resources while preserving its physician-led independence. The practice operates 18 locations across South Texas with 16 medical oncologists, 3 radiation oncologists and 23 advanced practitioners.
The partnership aims to enhance patient access to advanced therapies, reduce administrative burden, maintain local care delivery and support long-term sustainability for community-based oncology services.
American Oncology Network (AONC) partner practice Fort Wayne Medical Oncology and Hematology expanded services at Cameron Health in Angola, Indiana, effective March 4, 2026, to increase local access to comprehensive cancer care.
Renovations added an expanded lobby, dedicated registration, five new exam rooms, a private physician office and 12 infusion bays, plus support areas; the facility also recently installed a new linear accelerator. FWMOH will increase days of on-site medical oncology, hematology, infusion therapy and palliative/supportive services to serve rising cancer rates in Steuben County.
RKV Medical Center (AONC) in Muskogee, Oklahoma, joined American Oncology Network on Feb 4, 2026 as AON’s first partner practice in the state.
The partnership aims to expand access to clinical trials, advanced therapies, onsite infusion and radiation services, specialty pharmacy, centralized labs, and continued community-based care under Dr. Ravikumar Vasireddy.
Hematology Oncology of Indiana (AONC) announced that Dr. Amy Braden, DO, a board-certified medical oncologist and hematologist with over 10 years of experience, has joined its physician team and is accepting new patients as of February 3, 2026. Dr. Braden will see patients in Indianapolis, Logansport, and Noblesville.
The practice operates six locations across Indiana and offers specialty infusion, pathology, pharmacy, clinical trials, and BiTE therapy as part of community-based cancer care.
Genesis Cancer and Blood Institute (AONC) announced on Jan 21, 2026 the addition of board-certified endocrinologist Daryl Burrows, MD, and advanced practice nurse Natalie Brown, APRN to its Hot Springs team. The hires expand Genesis to offer onsite endocrinology alongside oncology across 11 Arkansas locations, enabling coordinated endocrine and cancer care at the Genesis Hot Springs—Higdon Ferry clinic.
The staff additions increase local access to diabetes and endocrine services within the community-based cancer practice.
American Oncology Research (AONC) and Meaningful Insights Biotech Analytics (MiBA) announced a strategic alliance on January 15, 2026 to integrate AI-enhanced real-world data into community-based clinical research.
The partnership embeds MiBA’s near-real-time RWD and AI workflows into the American Oncology Network to improve site feasibility, patient matching, enrollment speed, and trial access at the point of care via EMR-integrated insights. The alliance also targets improved trial equity and DAP-aligned enrollment strategies to reduce protocol amendments and support more representative data.
American Oncology Network (NASDAQ:AONC) and Lone Star Oncology announced that Derrick Nguyen, MD, FACP joined Lone Star Oncology's physician team and is accepting new patients as of Jan. 6, 2026. Dr. Nguyen is a Board-certified medical oncologist with over 15 years of practice, trained at the University of Texas Health Science Center and completed residency at the University of New Mexico Health Sciences Center.
Lone Star Oncology opened in June 2023 and joined AON, expanding local access to infusion therapy, centralized lab and pathology, oral oncolytic delivery and financial counseling through the network partnership.
American Oncology Network (NASDAQ:AONC) announced the appointment of Robert J. McDonald, MD, FACNM, as Radiology Medical Director and in-house reading radiologist, effective Dec. 10, 2025. Dr. McDonald will serve as primary reading radiologist for Florida Oncology & Hematology in Naples and Fort Myers and Central Georgia Cancer Care in Macon, provide PET/CT interpretations, perform advanced radiotheranostic therapies at Naples and Fort Myers, and oversee radiology services at supported practices.
He will lead NRC-required clinical preceptorships, refine RLT protocols, and support rollout of newly FDA-approved radiotheranostic therapies as AONC expands RLT capabilities into 2026. Dr. McDonald brings >30 years of diagnostic imaging and radioligand therapy experience.